Gelonghui, May 30丨Jingxin Pharmaceutical (002020.SZ) said on the investor interactive platform that the company's artificial large blood vessel project has now entered the small-scale human trial stage. The time to market also depends on the progress of testing and other related work.
京新药业(002020.SZ)：人工大血管项目目前已进入到小规模人体试验阶段
Jingxin Pharmaceutical (002020.SZ): The artificial large blood vessel project has now entered the small-scale human trial stage
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.